Second Senate Hearing about Outpatient Treatment for COVID-19: Highlights

This second US Senate committee hearing, convened by Senator Ron Johnson, featured six distinguished witnesses:

Ramin Oskoui, M.D. Vice President of Medica Staff, Sibley Memorial Hospital and Chief Executive Officer, Foxhall Cardiology
Jean-Jacques Rajter, M.D. Pulmonologist Broward Health Medical Center
Pierre Kory, M.D. Associate Professor of Medicine St. Luke’s Aurora Medical Center
Armand Balboni, M.D., PH.D. Chief Executive Officer Appili Therapeutics Inc.
Jane M. Orient, M.D. Executive Director Association of American Physicians and Surgeons
Jayanta Bhattacharya, M.D., PH.D. Professor of Medicine Stanford University and Senior Fellow Stanford Institute for Economic Policy Research Stanford University

These were very in depth discussions not only on early treatment, especially with Ivermectin, but also on the bigger picture of the devastating health, social and economic effects of the C19 crisis.

Absent from the first session, Senator Rand Paul was present and engaged the witnesses with important questions, including about RCTs. Senator Josh Hawley was also present, online, and asked questions about the implications of how the response to C19 has been implemented in the US.

Other US Senators member of the committee, including Kamals Harris and Mitt Romney, did not participate.

Democrat, ranking member, Senator Peters, was present, blasts the hearing and the witnesses even before listening to them, and did not ask a single question.

The video recording can be found at this link.

Here are highlights of the hearing, through a series of tweets. (and please blame Twitter for not keeping those in chronological order 🙂